212 related articles for article (PubMed ID: 3080463)
41. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
42. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
[TBL] [Abstract][Full Text] [Related]
43. Properties of spontaneous growth hormone secretory bursts and half-life of endogenous growth hormone in boys with idiopathic short stature. Genentech Collaborative Group.
Veldhuis JDP6 ; Blizzard RM; Rogol AD; Martha PM; Kirkland JL; Sherman BM
J Clin Endocrinol Metab; 1992 Apr; 74(4):766-73. PubMed ID: 1548338
[TBL] [Abstract][Full Text] [Related]
44. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
[TBL] [Abstract][Full Text] [Related]
45. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[TBL] [Abstract][Full Text] [Related]
46. Long term pulsatile growth hormone (GH)-releasing hormone therapy in children with GH deficiency.
Low LC; Wang C; Cheung PT; Ho P; Lam KS; Young RT; Yeung CY; Ling N
J Clin Endocrinol Metab; 1988 Mar; 66(3):611-7. PubMed ID: 3127420
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic markers of permanent idiopathic growth hormone deficiency.
Adan L; Souberbielle JC; Brauner R
J Clin Endocrinol Metab; 1994 Feb; 78(2):353-8. PubMed ID: 7508948
[TBL] [Abstract][Full Text] [Related]
48. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
49. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.
Attie KM; Ramirez NR; Conte FA; Kaplan SL; Grumbach MM
J Clin Endocrinol Metab; 1990 Oct; 71(4):975-83. PubMed ID: 2401720
[TBL] [Abstract][Full Text] [Related]
50. Relative importance of growth hormone and sex steroids for the growth at puberty of trunk length, limb length, and muscle width in growth hormone-deficient children.
Tanner JM; Whitehouse RH; Hughes PC; Carter BS
J Pediatr; 1976 Dec; 89(6):1000-8. PubMed ID: 993900
[TBL] [Abstract][Full Text] [Related]
51. Low urinary growth hormone values in patients with Turner's syndrome.
Kohno H; Honda S
J Clin Endocrinol Metab; 1992 Mar; 74(3):619-22. PubMed ID: 1740496
[TBL] [Abstract][Full Text] [Related]
52. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children.
Kaplan SL; Underwood LE; August GP; Bell JJ; Blethen SL; Blizzard RM; Brown DR; Foley TP; Hintz RL; Hopwood NJ
Lancet; 1986 Mar; 1(8483):697-700. PubMed ID: 2870221
[TBL] [Abstract][Full Text] [Related]
53. Growth hormone deficiency.
Gordon D
Scott Med J; 1987 Aug; 32(4):99-100. PubMed ID: 3118462
[TBL] [Abstract][Full Text] [Related]
54. Growth hormone deficiency in Down's syndrome children.
Castells S; Torrado C; Bastian W; Wisniewski KE
J Intellect Disabil Res; 1992 Feb; 36 ( Pt 1)():29-43. PubMed ID: 1533556
[TBL] [Abstract][Full Text] [Related]
55. Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.
Rudman D; Patterson JH; Gibbas DL
J Clin Invest; 1973 May; 52(5):1108-12. PubMed ID: 4700485
[TBL] [Abstract][Full Text] [Related]
56. Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity.
Bansal SA; Lee LA; Woolf PD
J Clin Endocrinol Metab; 1981 Dec; 53(6):1273-7. PubMed ID: 7028777
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of growth hormone secretion: provocative testing vs endogenous 24-hour growth hormone profile.
Shulman DI; Bercu BB
Acta Paediatr Scand Suppl; 1987; 337():61-71. PubMed ID: 3124498
[TBL] [Abstract][Full Text] [Related]
58. [Responses of somatotropin to stimuli after brief administration of estradiol in short children].
Garnier P; Roger M; Canlorbe P; Job JC
Arch Fr Pediatr; 1985; 42(6):423-7. PubMed ID: 4051672
[TBL] [Abstract][Full Text] [Related]
59. A comparison of subcutaneous and intramuscular administration of human growth hormone in the therapy of growth hormone deficiency.
Russo L; Moore WV
J Clin Endocrinol Metab; 1982 Nov; 55(5):1003-6. PubMed ID: 6889608
[TBL] [Abstract][Full Text] [Related]
60. Changes in serum leptin levels during r-hGH treatment in growth hormone-deficient children.
Wei H; Fang J; Wang M
J Tongji Med Univ; 2001; 21(4):332-3. PubMed ID: 12539563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
